Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2869112rdf:typepubmed:Citationlld:pubmed
pubmed-article:2869112lifeskim:mentionsumls-concept:C0025255lld:lifeskim
pubmed-article:2869112lifeskim:mentionsumls-concept:C0019564lld:lifeskim
pubmed-article:2869112lifeskim:mentionsumls-concept:C0086045lld:lifeskim
pubmed-article:2869112lifeskim:mentionsumls-concept:C0332157lld:lifeskim
pubmed-article:2869112lifeskim:mentionsumls-concept:C0005456lld:lifeskim
pubmed-article:2869112lifeskim:mentionsumls-concept:C0220839lld:lifeskim
pubmed-article:2869112lifeskim:mentionsumls-concept:C1148573lld:lifeskim
pubmed-article:2869112lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:2869112lifeskim:mentionsumls-concept:C0243071lld:lifeskim
pubmed-article:2869112lifeskim:mentionsumls-concept:C0205374lld:lifeskim
pubmed-article:2869112pubmed:issue2lld:pubmed
pubmed-article:2869112pubmed:dateCreated1986-4-11lld:pubmed
pubmed-article:2869112pubmed:abstractTextThe number of Na+-independent, Cl--dependent glutamate binding sites in rat hippocampal membranes is increased two- to fourfold after pre-exposing isolated membranes or hippocampal slices to high concentrations (0.1-10 mM) of L-glutamate or of glutamate analogs with high affinity for this binding site, such as quisqualate, homocysteate, or aminoadipate. N-Methylaspartate and kainate are ineffective. A similar binding increase is induced by transient exposure to the dipeptide tyrosylglutamate. The newly induced binding sites appear to be identical with pre-existing Cl--dependent binding sites by several criteria: They have a similar pharmacological profile, they are sensitive to low concentrations of Na+, and the number of sites can be further increased by transient exposure to micromolar calcium concentrations. Moreover, binding of [3H]APB, a ligand selective for the Cl--dependent glutamate binding sites, is also increased after glutamate preincubation. The induction of binding sites by high glutamate concentrations, described herein, is calcium-independent, not inhibited by leupeptin and, therefore, different from the previously described activation of binding sites by a calcium-sensitive protease. The high concentration of ligand needed to induce increased binding suggests the presence in hippocampal membranes of a binding site with low, millimolar affinity that is functionally related to the known high-affinity binding sites. Several interpretations of the observed effects and their implications for the possible relationship between the binding site and the synaptic receptor are discussed.lld:pubmed
pubmed-article:2869112pubmed:languageenglld:pubmed
pubmed-article:2869112pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2869112pubmed:citationSubsetIMlld:pubmed
pubmed-article:2869112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2869112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2869112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2869112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2869112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2869112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2869112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2869112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2869112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2869112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2869112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2869112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2869112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2869112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2869112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2869112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2869112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2869112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2869112pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2869112pubmed:statusMEDLINElld:pubmed
pubmed-article:2869112pubmed:monthFeblld:pubmed
pubmed-article:2869112pubmed:issn0270-6474lld:pubmed
pubmed-article:2869112pubmed:authorpubmed-author:KesslerMMlld:pubmed
pubmed-article:2869112pubmed:authorpubmed-author:CumminsJ TJTlld:pubmed
pubmed-article:2869112pubmed:authorpubmed-author:BaudryMMlld:pubmed
pubmed-article:2869112pubmed:authorpubmed-author:LynchGGlld:pubmed
pubmed-article:2869112pubmed:authorpubmed-author:WaySSlld:pubmed
pubmed-article:2869112pubmed:issnTypePrintlld:pubmed
pubmed-article:2869112pubmed:volume6lld:pubmed
pubmed-article:2869112pubmed:ownerNLMlld:pubmed
pubmed-article:2869112pubmed:authorsCompleteYlld:pubmed
pubmed-article:2869112pubmed:pagination355-63lld:pubmed
pubmed-article:2869112pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2869112pubmed:meshHeadingpubmed-meshheading:2869112-...lld:pubmed
pubmed-article:2869112pubmed:meshHeadingpubmed-meshheading:2869112-...lld:pubmed
pubmed-article:2869112pubmed:meshHeadingpubmed-meshheading:2869112-...lld:pubmed
pubmed-article:2869112pubmed:meshHeadingpubmed-meshheading:2869112-...lld:pubmed
pubmed-article:2869112pubmed:meshHeadingpubmed-meshheading:2869112-...lld:pubmed
pubmed-article:2869112pubmed:meshHeadingpubmed-meshheading:2869112-...lld:pubmed
pubmed-article:2869112pubmed:meshHeadingpubmed-meshheading:2869112-...lld:pubmed
pubmed-article:2869112pubmed:meshHeadingpubmed-meshheading:2869112-...lld:pubmed
pubmed-article:2869112pubmed:meshHeadingpubmed-meshheading:2869112-...lld:pubmed
pubmed-article:2869112pubmed:meshHeadingpubmed-meshheading:2869112-...lld:pubmed
pubmed-article:2869112pubmed:meshHeadingpubmed-meshheading:2869112-...lld:pubmed
pubmed-article:2869112pubmed:meshHeadingpubmed-meshheading:2869112-...lld:pubmed
pubmed-article:2869112pubmed:meshHeadingpubmed-meshheading:2869112-...lld:pubmed
pubmed-article:2869112pubmed:meshHeadingpubmed-meshheading:2869112-...lld:pubmed
pubmed-article:2869112pubmed:meshHeadingpubmed-meshheading:2869112-...lld:pubmed
pubmed-article:2869112pubmed:meshHeadingpubmed-meshheading:2869112-...lld:pubmed
pubmed-article:2869112pubmed:meshHeadingpubmed-meshheading:2869112-...lld:pubmed
pubmed-article:2869112pubmed:meshHeadingpubmed-meshheading:2869112-...lld:pubmed
pubmed-article:2869112pubmed:meshHeadingpubmed-meshheading:2869112-...lld:pubmed
pubmed-article:2869112pubmed:meshHeadingpubmed-meshheading:2869112-...lld:pubmed
pubmed-article:2869112pubmed:meshHeadingpubmed-meshheading:2869112-...lld:pubmed
pubmed-article:2869112pubmed:meshHeadingpubmed-meshheading:2869112-...lld:pubmed
pubmed-article:2869112pubmed:meshHeadingpubmed-meshheading:2869112-...lld:pubmed
pubmed-article:2869112pubmed:year1986lld:pubmed
pubmed-article:2869112pubmed:articleTitleInduction of glutamate binding sites in hippocampal membranes by transient exposure to high concentrations of glutamate or glutamate analogs.lld:pubmed
pubmed-article:2869112pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2869112pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2869112lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2869112lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2869112lld:pubmed